Next CRES Seminars
3/02/2010 Meritxell Solé (Universitat de Barcelona), "Las condiciones de trabajo como determinantes de las desigualdades socioeconómicas en salud: ¿hay diferencias entre inmigrantes y autóctonos en España?"CRES Seminars 2007-2008
2/12/09 Jeffrey E. Harris (Massachusetts Institute of Technology ,MIT): "Why We Don't Have An HIV Vaccine, And How We Can Develop One"
7/10/2009 Rhema Vaithianathan (University of Auckland): "Truth-In-Advertising Laws and Pharmaceutical Promotion"
Direct-to-consumer advertising of prescription drugs (DTCA) is heavily regulated. Nelson (1974) provides an informal argument that improved regulation of advertising increases its credibility and therefore the incentives to advertise. He concludes that tighter regulation will stimulate advertising of true claims and that "moderately enforced" regulation will encourage false advertising. We show formally how Nelson's intuition applies to DTCA, even though a "learned intermediary" - the physician - stands between the consumer and the drug company.
14/05/2009 Federico A. Todeschini (Universitat Pompeu Fabra): "The effect of smoking on body mass index: evidence from cohort data"
17/04/2009 Norma A. Padrón (Universitat Pompeu Fabra): "Preferences, Beliefs and Self-Management of Diabetes" (with J Frank A. Sloan and Alyssa C. Platt)
|
Objective. To assess relationships between self-assessed control over life events, subjective beliefs about longevity, time and risk preference, and other factors on use of recommended care for diabetes mellitus (DM), self-assessed control of diabetes, general health, and laboratory measures of HbA1c levels. Data Sources. Health and Retirement Study (HRS) and 2003 HRS Diabetes Study (HRS-DS). Study Design. We used logit and ordered logit analyses to assess use of recommended care, and subjective and objective measures of health outcomes. Data Collection. Secondary analysis of HRS and HRS-DS data. Principal Findings. Individuals with higher self-assessed control over life events and higher subjective probabilities of living 10 years engaged in more recommended DM care practices, and had better self-assessed DM control and general health. However, these beliefs did not influence HbA1c levels. More highly educated and cognitive able persons were more likely to follow care recommendations. There were differences by race/ethnicity in health outcomes, but not in health investment among Hispanics. Conclusions. Individuals' beliefs about control over life events and longevity influenced health investment and subjective health outcomes, although these beliefs did not translate into differences inHbA1c levels. Hispanics may realize lower returns on health investments, at least for diabetes care. |
27/02/2009 Javier Coronado (NERA): "Entry in a Regulated Pharmaceutical Market"
21/01/2009 Joan Ramon Borrell (Universitat de Barcelona): "Assessing excess profits from different entry regulations"
| Entry regulations affecting professional services such as pharmacies are common practice in many European countries. We assess the impact of entry regulations on proffits estimating a structural model of entry using the information provided by a policy experiment. We use the case of different regional policies governing the opening of new pharmacies in Spain to show that structural models of entry ought to be estimated with data from policy experiments to pin down how entry regulations change payoff functions of the incumbents. Contrary to the public interest rationales, regulations are not only boosting small pharmacist payoffs nor increasing all pharmacies payoffs alike. The gains from regulations are very unevenly distributed, suggesting that private interest are shaping the current mix of entry and markup regulations. |
18/12/2008 Climent Quintana-Domeque (Universitat d'Alacant): "A look at the lives of the unemployed in Catalonia: preliminary evidence from the Catalan Health Survey 2006”.
24/11/2008 Maarten Lindeboom (Vrije Universiteit Amsterdam): “When dreams do not come true: the ex-ante effect of a change in the retirement system on the mental health of workers nearing retirement”
5/11/2008 Donald J Wright (University of Sydney): "Medical Malpractice and Physician Liability Under a Negligence Rule"
| This paper develops a model of medical malpractice claims to examine the impact of physicians being liable for actual damage under a negligence rule. It is found that this arrangement does not provide strong incentives for physicians to attain the socially optimal level of expertise nor quality of service. The incentive effects of physicians being liable for actual damage can be strengthened by the central provision of publicly available information that assists patients to accurately determine whether their health outcome was more likely the result of medical malpractice rather than just a poor outcome from the correct diagnosis or treatment. |
22/10/2008 Mônica Viegas Andrade (Universidade Federal de Minas Gerais, Brasil): "Prevention and Control of Homicides: An Impact Evaluation in Brazil"
| In this article we assess the impact of Fica Vivo programme. Fica Vivo is a social program built for prevention and control of criminality, set up in Brazil. Its design is inspired by the American programme CeaseFire and the principal objective is the reduction of homicides in areas where its incidence is high, in general, slums. The impact variable is th half-yearly homicide rate per one hundred thousand inhabitants and the methodology used is Double Difference Matching (DDM). We utilize a specification of the model that allows us to consider the impact of the programme in a differentiated way for each area treated and for each stage of programm expansion. The data utilized are the georeferenced records of the Military Police of Minas Gerais running from 2000 to 2006, and data from the demographic census of 2000. The principal results indicate that Fica Vivo reduces criminality, although the effect of the programme is not homogeneous over the areas treated, and has increased with the passage of time during the period studied. |
03/07/2008 Andrew Street (Centre for Health Economics, University of York): "Measurement of health system output growth"
18/06/2008 Claudia Desogus (U. de Bologna): "Does parallel trade on pharmaceuticals undermine R&D incentives? Shaping an appropriate ‘efficiency defence’ under European competition law".
02/06/2008 Juan-Rafael Vargas (Universidad de Costa Rica): TBA
20/05/2008 Anna Cabré (Centre d'Estudis Demogràfics, Universitat Autònoma de Barcelona): Viure Cent Anys? Reflexió des de la Demografia Pospuesto
05/05/2008 Iván Moreno Torres (CRES, Universitat Pompeu Fabra): "Demanda de Medicamentos: La competencia de los genéricos en un mercado farmacéutico regulado"
01/04/2008 Ipek Aktar (UPF) "Volluntary Full Transparency (Registry and Disclosure) of Clinical Trials by Pharmaceuticals"
07/03/2008 Bernard van den Berg (Institute of Health Sciences. VU University Amsterdam) "Economic evaluation of informal care"
24/01/2008 David Casado (UPF) "Impacte de l'envelliment sobre les necessitats de finançament sanitari a Catalunya: Projeccions fins l'any 2030"
5/12/2007 Begoña García (Comissió del Mercat de Telecomunicacions) "External referencing, pharmaceutical price negotiations and others"
|
"External referencing imposes a price cap for pharmaceuticals based on prices of identical products in other countries. Suppose country A negotiates prices with a pharmaceutical firm while country B can either do the same or base her external referencing on A´s price. We show that B may prefer the latter option if drug copayments in B are sufficiently high and that the effects of external referencing crucially depend on whether it is conditioned on the drug being listed in A or not. Country B will never implement non conditional ER, who instead will find that different sorts of conditional referencing are worth pursuing. We show that size effects are relatively small." |